Senator Moreno BRUTALLY DESTROYS ENTIRE Liberal Law Makers Over Obamacare SCAM in a FIERY CLASH.

Introduction

In a heated Senate hearing that was expected to be a routine defense of the Affordable Care Act (ACA), commonly known as Obamacare, Senator Moreno transformed the session into a scathing critique of the law’s promises, outcomes, and political legacy. The exchange between Moreno, witnesses, and Democratic senators laid bare the deep frustrations and unresolved issues that continue to haunt the American healthcare system more than a decade after the ACA’s passage.

This article provides an in-depth analysis of the hearing, examining the arguments presented, the evidence cited, and the broader context of Obamacare’s impact on American families, insurance companies, and the political landscape. Through careful review of the transcript and supporting research, we seek to understand the roots of the controversy and the challenges that remain in delivering affordable, effective healthcare to all Americans.

The Hearing: From Defense to Confrontation

The session began with the expectation of a familiar script: Democratic senators praising Obamacare for expanding access, providing protections for pre-existing conditions, and making healthcare more affordable. However, Senator Moreno quickly shifted the tone, challenging witnesses and colleagues to answer for what he described as the “biggest lies propping up the law.”

Moreno’s central argument focused on a promise made by President Obama during the ACA’s rollout: that “premiums will drop and the average family will see premiums go down by $2,500 a year in 2014.” Moreno pressed Mr. White, a witness at the hearing, to confirm whether this promise was ever fulfilled. The answer was unequivocal: “No.” Moreno insisted that not a single American family had seen such savings, and that the law had instead enriched insurance companies at the expense of ordinary citizens.

The Premiums Promise: Fact vs. Reality

The $2,500 premium reduction became a symbol of the ACA’s aspirations. President Obama and supporters repeatedly cited this figure as evidence that reform would ease the financial burden on families. Yet, as Moreno and Mr. White discussed, the reality was starkly different.

Research shows that while some Americans benefited from subsidies and expanded Medicaid, premiums for many in the individual market rose sharply. According to a 2023 report by the Kaiser Family Foundation, average premiums for employer-sponsored plans increased by over 55% between 2010 and 2022, outpacing inflation and wage growth. For those purchasing insurance on the exchanges, costs varied widely, with many facing higher deductibles and narrower provider networks.

Moreno’s critique resonated with millions who feel squeezed by rising healthcare costs. The promise of $2,500 in annual savings remains unfulfilled for most, fueling skepticism about the ACA’s effectiveness and honesty.

The Winners: Insurance Companies and Corporate Profits

One of the most striking moments in the hearing was Moreno’s comparison of United Healthcare’s growth before and after Obamacare. In 2015, United Healthcare’s stock traded at $115 per share; by 2024, it had soared to over $600. The company’s market value ballooned from $108 billion to nearly $600 billion, making it larger than Ford Motor Company and rivaling the combined value of most major automakers (excluding Tesla).

This explosive growth, Moreno argued, was a direct result of the ACA’s structure, which mandated coverage and expanded the customer base for insurance companies. While insurers faced new regulations and limits on profit margins, the influx of government subsidies and millions of new customers proved highly lucrative.

Critics contend that the ACA failed to rein in corporate profits and instead shifted costs onto consumers. Moreno’s analysis underscores the perception that healthcare reform enriched large companies while leaving many Americans struggling to pay for basic care.

The Uninsured and the Cost of Care

Moreno also addressed the issue of uninsured individuals, particularly those who enter the country illegally. While undocumented immigrants are not eligible for Medicare, Medicaid, or ACA exchanges, they can receive emergency care at hospitals, often at no charge. Moreno argued that the cost of these services is ultimately shifted onto insured Americans, driving up premiums and overall healthcare expenses.

Estimates vary, but the American Hospital Association reports that uncompensated care costs U.S. hospitals over $40 billion annually. While some of this burden is offset by federal and state funding, the remainder is absorbed by providers and, indirectly, by other patients through higher prices.

The debate over how to address the needs of uninsured and undocumented individuals remains contentious, with no easy solutions in sight.

The Transparency Challenge

Moreno highlighted another persistent problem: the lack of price transparency in healthcare. Unlike other industries, patients often do not know the cost of services until weeks or months after receiving care. Moreno recounted his own experience paying for an MRI, noting the wide disparity between cash prices and insurance-negotiated rates.

Efforts to improve transparency have gained momentum in recent years, with federal rules requiring hospitals to post prices online and insurers to disclose negotiated rates. However, compliance has been uneven, and many consumers still struggle to compare costs or understand their bills.

Transparency advocates argue that greater visibility would empower patients to shop for care, drive competition, and lower prices. Moreno’s testimony suggests that real reform must address not only coverage but also the opaque pricing practices that frustrate millions.

Proposed Solutions: Beyond Political Theater

Throughout the hearing, Moreno pressed for concrete reforms, including:

Association Health Plans: Allowing small businesses and individuals to band together to purchase coverage, potentially reducing premiums by up to 30%.
Pharmacy Benefit Manager (PBM) Reform: Addressing the role of middlemen in driving up drug prices.
Most Favored Nation Status for Drugs: Negotiating lower prices by matching the best deals offered in other countries.
Tort Reform: Reducing the cost of malpractice litigation and defensive medicine.
Expanded Health Savings Accounts: Giving consumers more control over their healthcare dollars.
Administrative Cost Reduction: Streamlining paperwork and bureaucracy to lower overhead.